Latisse Faces Patent Challenge
The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version. (Source: WSJ.com: Health)
See the rest here:
Latisse Faces Patent Challenge
Comments
Leave a Reply
